Sphera Funds Management Ltd. Cytom X Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$9.5 - $19.16 $855,000 - $1.72 Million	-90,000 Reduced 32.95%	183,151 $1.97 Million
Q4 2018 Feb 14, 2019	BUY	$12.69 - $18.61 $507,600 - $744,400	40,000 Added 17.16%	273,151 $4.13 Million
Q3 2018 Nov 14, 2018	BUY	$18.04 - $26.41 $2.71 Million - $3.96 Million	150,009 Added 180.43%	233,151 $4.31 Million
Q2 2018 Aug 13, 2018	SELL	$21.38 - $29.68 $2.07 Million - $2.87 Million	-96,858 Reduced 53.81%	83,142 $1.9 Million
Q1 2018 May 10, 2018	BUY	$21.76 - $34.22 $435,200 - $684,400	20,000 Added 12.5%	180,000 $5.12 Million
Q4 2017 Feb 12, 2018	SELL	$19.0 - $23.09 $950,000 - $1.15 Million	-50,000 Reduced 23.81%	160,000 $3.38 Million
Q3 2017 Nov 09, 2017	BUY	$13.53 - $18.17 $2.84 Million - $3.82 Million	210,000	210,000 $3.82 Million

50.4M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $66M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.